Join to access to all OVN content. Join for Free
Filler Words Fix the Problem You Didn't Know You Had
filler words communication skills professional presence audience engagement verbal fillers

Filler Words Fix the Problem You Didn't Know You Had


Share This Article


Summary

In this episode, Tom Caravela delves into the significance of eliminating filler words in professional as well as personal communication. He highlights the impact of these verbal fillers on perceived competence and interview performance, supported by revealing statistics. Tom explores the demographic differences in the use of filler words and their effects on audience engagement. He provides practical strategies for reducing filler words, emphasizing the importance of preparation, practice, and the power of slowing down and pausing. The episode concludes with insights on mindfulness and self-awareness in speech, encouraging listeners to refine their communication skills for enhanced professional presence.

Key Points

  • Eliminating filler words can significantly enhance your professional image, making you appear more confident and competent.
  • Preparation and practice are key to eliminating the need to fill gaps with habitual words.
  • Slowing down and embracing pauses in your speech can improve clarity and engagement, preventing the need for filler words.

Click for Source
filler words, communication skills, professional presence, audience engagement, verbal fillers

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Be Brave-A Networking Tale that Led to Friendship
Partner Avatar MSL Talk, Tom Caravela, Josh Yoder, Kirsten Borbe

Be Brave-A Networking Tale that Led to Friendship

Podcast
Top 5 MSL Frustrations and How to Overcome Them
Partner Avatar MSL Talk: Tom Caravela

Top 5 MSL Frustrations and How to Overcome Them

Article
Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions
OVN Avatar Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH

Virtual Clinical Trials in Oncology-Overview, Challenges, Policy Considerations, and Future Directions

Article
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
OVN Avatar Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin

Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years

Article
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
OVN Avatar Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS

Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review

Article
Transforming oncology: Five frontiers driving progress in cancer care
Partner Avatar iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

Explore OVN